EyeGate Pharmaceuticals, Inc (EYEG)

Etorro trading 970x250
EyeGate Pharmaceuticals, Inc (EYEG) Logo

About EyeGate Pharmaceuticals, Inc

EyeGate Pharmaceuticals, Inc., a clinical-stage specialty pharmaceutical company, focuses on developing and commercializing products for treating diseases and disorders of the eye in the United States. Its proprietary platform technologies consist of crosslinked thiolated carboxymethyl hyaluronic acid (CMHA-S) and iontophoresis drug delivery system. The company’s CMHA-S based product, the EyeGate Ocular Bandage Gel, a topically-applied eye drop formulation that has completed its first-in-man clinical trial for the management of corneal epithelial wounds, defects, and epitheliopathies, as well as for re-epithelization of the ocular surface. It is also developing EGP-437 for the treatment of various inflammatory conditions of the eye, including the treatment of ocular inflammation and pain in post-surgical cataract patients and anterior uveitis; and Eyegate II drug delivery system. The company has license agreements with the University of Miami School of Medicine; BioTime, Inc.; and the University of Utah Research Foundation. Eyegate Pharmaceuticals, Inc. was incorporated in 1998 and is headquartered in Waltham, Massachusetts. Address: 271 Waverley Oaks Road, Waltham, MA, United States, 02452

EyeGate Pharmaceuticals, Inc News and around…

Latest news about EyeGate Pharmaceuticals, Inc (EYEG) common stock and company :

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
01 Oct, 2021 FinancialContent

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning, investor! The final day of the workweek is here and with it comes a look at the pre-market stock movers for Friday! The post Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS Now Analyst Who Found Microsoft at $0.38 Names #1 Pick for the AI Boom America’s #1 EV Stock Still Flying Under the Radar

12 Health Care Stocks Moving In Thursday's Intraday Session
30 Sep, 2021 FinancialContent

Gainers Progenity (NASDAQ:PROG) stock increased by 21.06% to $1.31 during Thursday's regular session. The current ...

EYEG: Refreshed and moving forward
30 Sep, 2021 Yahoo! Finance

By Beth Senko, CFA NASDAQ:EYEG READ THE FULL EYEG RESEARCH REPORT The past year has been one of much change at EyeGate Pharmaceuticals (NASDAQ:EYEG). The pipeline has expanded from one to three candidates (with multiple possible indications). The Company has raised over $20 million in funding and added key clinical and management hires. We expect a series of clinical milestones over the next

7 Best Penny Stocks to Buy on the Nasdaq for October
29 Sep, 2021 FinancialContent

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Penny stocks have a place in every portfolio when adjusted for risk. These 7 have the added safety of a Nasdaq listing. The post 7 Best Penny Stocks to Buy on the Nasdaq for October appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS Now Analyst Who Found Microsoft at $0.38 Names #1 Pick for the AI Boom America’s #1 EV Stock Still Flying Under the Radar

Best Penny Stocks to Buy Right Now? 3 to Watch in October
24 Sep, 2021 FinancialContent
Penny Stocks For Your Biotech Watch List In September 2021
15 Sep, 2021 FinancialContent
46 Biggest Movers From Yesterday
15 Sep, 2021 FinancialContent

Gainers Communications Systems, Inc. (NASDAQ: JCS) jumped 39.4% to close at $9.41 on Tuesday as the company declared a special ...

4 Penny Stocks To Buy According To Analysts & Price Targets Up To 507%
14 Sep, 2021 FinancialContent
36 Stocks Moving In Tuesday's Mid-Day Session
14 Sep, 2021 FinancialContent

Gainers FuelCell Energy, Inc. (NASDAQ: FCEL) shares jumped 26% to $7.08 after the company reported better-than-expected Q3 ...

20 Stocks Moving in Tuesday's Pre-Market Session
14 Sep, 2021 FinancialContent

Gainers Communications Systems, Inc. (NASDAQ: JCS) rose 34.8% to $9.15 in pre-market trading as the company declared a special ...

EyeGate to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
09 Sep, 2021 FinancialContent
EyeGate Pharma Completes Target Enrollment in Phase 2 Proof-of-Concept Study to Evaluate PP-001 for the Treatment of Ocular Surface Inflammation
08 Sep, 2021 FinancialContent
Top Penny Stocks You Need to Know About Right Now
20 Aug, 2021 FinancialContent
The Daily Biotech Pulse: Coherus Soars On Lung Cancer Data, Illumina Closes On Grail Buy Without Regulatory Clearance, Adagene Strikes Collaboration With Merck
19 Aug, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...

12 Health Care Stocks Moving In Wednesday's Intraday Session
18 Aug, 2021 FinancialContent

Gainers PharmaCyte Biotech (NASDAQ:PMCB) shares rose 119.0% to $7.49 during Wednesday's regular session. Trading ...

The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business
17 Aug, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...

12 Health Care Stocks Moving In Friday's After-Market Session
13 Aug, 2021 FinancialContent

Gainers Cellect Biotechnology (NASDAQ:APOP) shares rose 22.05% to $4.76 during Friday's after-market session. At the close, Cellect ...

The Daily Biotech Pulse: Moderna's Vaccine Produces Durable Response Against Variants, FDA Approves Jazz's Sleep Disorder Drug, Dermata IPO
13 Aug, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...

EyeGate Pharma Reports Second Quarter 2021 Financial Results and Provides Business Update
12 Aug, 2021 FinancialContent
The Daily Biotech Pulse: Xeris Gets OK For Initiating Hyperthyroidism Study, Merck-Eisai Snag FDA Approval For Drug Combo, Decision Day For Jazz Pharma
12 Aug, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...

EyeGate Announces Closing of $10.75 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
11 Aug, 2021 FinancialContent
The Daily Biotech Pulse: FDA Rejects FibroGen's Anemia Drug, Crinetics Gains On Positive Readout, BioCryst Withdraws Public Offering
11 Aug, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...

85 Biggest Movers From Yesterday
11 Aug, 2021 FinancialContent

Gainers Fulcrum Therapeutics, Inc. (NASDAQ: FULC) jumped 125.3% to close at $18.77 on Tuesday after the company announced positive ...

Mid-Afternoon Market Update: 3D Systems Surges On Upbeat Earnings; Katapult Shares Drop
10 Aug, 2021 FinancialContent

Toward the end of trading Tuesday, the Dow traded up 0.49% to 35,274.95 while the NASDAQ fell 0.41% to 14,799.03. The S&P also rose, ...

Mid-Day Market Update: Crude Oil Rises Over 3%; comScore Shares Plummet
10 Aug, 2021 FinancialContent

Midway through trading Tuesday, the Dow traded up 0.37% to 35,231.28 while the NASDAQ fell 0.62% to 14,767.78. The S&P also fell, ...

54 Stocks Moving In Tuesday's Mid-Day Session
10 Aug, 2021 FinancialContent

Gainers Fulcrum Therapeutics, Inc. (NASDAQ: FULC) climbed 79.3% to $14.93 after the company announced positive interim results ...

Stocks That Hit 52-Week Lows On Tuesday
10 Aug, 2021 FinancialContent

Before 10 a.m. ET on Tuesday, 60 companies set new 52-week lows. Key Facts: PACCAR (NASDAQ:PCAR) was the ...

12 Health Care Stocks Moving In Tuesday's Pre-Market Session
10 Aug, 2021 FinancialContent

Gainers Arcturus Therapeutics (NASDAQ:ARCT) shares rose 25.93% to $60.75 during Tuesday's pre-market session. The ...

The Daily Biotech Pulse: Arcturus Soars On COVID-19 Vaccine Updates, Merck's Keytruda On Track For More Label Expansions, Eliem Debuts
10 Aug, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...

EyeGate Announces $10.75 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
10 Aug, 2021 FinancialContent

EyeGate Pharmaceuticals, Inc (EYEG) is a NASDAQ Common Stock listed in , ,

970x250